FACTORS IMPACTING TIME TO ENGRAFTMENT IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT

被引：0
|
作者：
Hillier, Kirsty [1 ]
Foster, Jennifer [1 ]
Cheng, W. [1 ]
机构：
[1] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
835
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Factors impacting time to engraftment in patients with high-risk neuroblastoma following autologous stem cell transplant
    Hillier, Kirsty
    Krance, Robert
    Foster, Jennifer Haunani
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant
    Hillier, Kirsty
    Cheng, W. Susan
    Whittle, Sarah B.
    Krance, Robert
    Foster, Jennifer H.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (07) : E569 - E574
  • [3] Clinical Prognostic Factors in Patients with High-risk Neuroblastoma Undergoing A Single Autologous Stem Cell Transplant
    Saito, Yuya
    Kiyotani, Chikako
    Inoue, Masami
    Takahashi, Yoshiyuki
    Ogawa, Atsushi
    Chin, Motoaki
    Koga, Yuuki
    Kato, Koji
    Koh, Katsuyoshi
    Watanabe, Kenichiro
    Hashii, Yoshiko
    Sato, Atsushi
    Atsuta, Yuko
    Matsumoto, Kimikazu
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S42 - S42
  • [4] Immune Reconstitution Following Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma at the Time of Immunotherapy
    Nassin, Michele L.
    Nicolaou, Elitsa
    Gurbuxani, Sandeep
    Cohn, Susan L.
    Cunningham, John M.
    LaBelle, James L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : 452 - 459
  • [5] EARLY INFECTIOUS COMPLICATIONS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR HIGH-RISK NEUROBLASTOMA: HIGH IMPACT ON MORTALITY AND MORBIDITY
    Noun, Dolly
    Ghanem, Khaled
    Dhayni, Raghida
    Hariss, Nariman
    Muakkit, Samar
    Saab, Raya
    Hamideh, Dima
    El-Solh, Hassan
    Abboud, Miguel
    Tarek, Nidale
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [6] Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta
    Jain, Richa
    Trehan, Amita
    Menon, Prema
    Kapoor, Rakesh
    Kakkar, Nandita
    Radhika, Srinivasan
    Saxena, Akshay Kumar
    Mittal, Bhagwant Rai
    Varma, Neelam
    Samujh, Ram
    Bansal, Deepak
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (04) : 291 - 304
  • [7] ACQUIRED HEMOPHILIA A FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK NEUROBLASTOMA
    Mitani, Yuichi
    Arakawa, Yuki
    Mori, Makiko
    Fukuoka, Kohei
    Oshima, Koichi
    Niitsu, Takehiro
    Kawashima, Hiroshi
    Fujinaga, Shuichiro
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [8] Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma
    Tolbert, Vanessa P.
    Dvorak, Christopher C.
    Golden, Carla
    Vissa, Madhav
    El-Haj, Nura
    Perwad, Farzana
    Matthay, Katherine K.
    Vo, Kieuhoa T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (10) : 2031 - 2039
  • [9] Optimizing Autologous Stem Cell Transplant for High-Risk Patients with Plasma Cell Dyscrasias
    Ali, Naveed
    Cooper, Brenda W.
    Kolk, Merle
    Creger, Richard
    Hoffman, Gina
    Lazarus, Hillard M.
    Tomlinson, Ben K.
    Caimi, Paolo
    Metheny, Leland
    de Lima, Marcos
    Malek, Ehsan
    BLOOD, 2017, 130
  • [10] Optimizing AUtologous Stem Cell Transplant for High-Risk Patients with Plasma Cell Dyscrasias
    Malek, Ehsan
    Hoffman, Gina
    Creger, Richard
    Cooper, Brenda
    Kolk, Merle
    Lazarus, Hillard M.
    Tomlinson, Benjamin
    Caimi, Paolo
    Metheny, Leland
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S133 - S133
12345